petroleum ether) using petroleum ether/dichloromethane mixtures as an eluent, and the isolated products were
analyzed by spectroscopic methods.
4.2.1. Spiro[adamantane-2,2’-(3’-phenyl-5’-trifluoromethyl-2’,3’-dihydro-1’,3’,4’-thiadiazole)] (9a):
Reaction time 2h; FCC (SiO2, petroleum ether/CH2Cl2 4:1), pale yellow solid, 218 mg (62%); mp
1
7677 °C. H NMR (600 MHz, CDCl3): 1.52, 1.71, 1.83, 2.072.09, 2.36 (5 m, 2H, 2H, 4H, 4H, 2H, Ad),
7.33-7.39, 7.517.53 (2 m, 3H, 2H, Ph) ppm; 13C NMR (CDCl3, 151 MHz): 26.4, 32.9, 37.5, 37.8, 38.1 (Ad),
1
2
97.5 (s, spiro-C), 119.8 (q, JC-F = 272.9 Hz, CF3), 128.7, 129.0, 130.2, 142.8 (3 d, s, Ph), 144.1 (q, JC-F = 37.9
Hz, C-5) ppm; 19F NMR (CDCl3, 188 MHz): –65.1 (s, CF3) ppm; IR (KBr): v 29372854, 1596, 1331, 1194,
1149, 1137, 1024, 1008, 964, 774, 701 cm-1; HRMS (ESI-TOF): m/z [M+H]+ calcd for C18H20F3N2S: 353.1299;
found: 353.1292.
4.2.2. Spiro{adamantane-2,2’-[3’-(p-tolyl)-5’-trifluoromethyl-2’,3’-dihydro-1’,3’,4’-thiadiazole]} (9b):
Reaction time 2h; FCC (SiO2, petroleum ether/CH2Cl2 85:15), colorless solid, 293 mg (80%); mp 7071
1
C. H NMR (600 MHz, CDCl3): 1.52, 1.71, 1.83, 2.082.10, 2.34 (5 m, 2H, 2H, 4H, 4H, 2H, Ad), 2.36 (s,
3H, Me), 7.16-7.17, 7.397.41 (2 m, 2H, 2H, Tol) ppm; 13C NMR (CDCl3, 151 MHz): 21.2 (q, Me), 26.4,
33.0, 37.7, 37.8, 38.1 (Ad), 97.6 (s, spiro-C), 119.8 (q, 1JC-F = 272.9 Hz, CF3), 129.6, 129.9, 138.6, 140.1 (2 d, 2
2
s, Tol), 144.0 (q, JC-F = 37.7 Hz, C-5) ppm; 19F NMR (CDCl3, 188 MHz): –65.1 (s, CF3) ppm; IR (KBr): v
29612906, 1507, 1452, 1334, 1216, 1132, 1024, 1010, 961, 825 cm-1; HRMS (ESI-TOF): m/z [M+H]+ calcd for
C19H22F3N2S: 367.1456; found: 367.1449.
4.2.3. Spiro{adamantane-2,2’-[3’-(4’’-methoxyphenyl)-5’-trifluoromethyl-2’,3’-dihydro-1’,3’,4’-thiadiazole]}
(9c)
1
Reaction time 4h; FCC (SiO2, petroleum ether/CH2Cl2 7:3), pale yellow oil, 244 mg (64%). H NMR
(600 MHz, CDCl3): 1.44, 1.71, 1.83, 2.08-2.10, 2.31 (5 m, 2H, 2H, 4H, 4H, 2H, Ad), 3.81 (s, 3H, OMe),
6.866.88, 7.427.45 (2 m, 2H, 2H, C6H4) ppm; 13C NMR (CDCl3, 151 MHz): 26.4, 33.0, 37.7, 37.9, 38.1
(Ad), 55.4 (q, OMe), 97.6 (s, spiro-C), 114.0 (d, C6H4), 119.8 (q, 1JC-F = 272.9 Hz, CF3), 131.2 (d, C6H4), 135.2
2
(s, C6H4), 144.0 (q, JC-F = 37.8 Hz, C-5), 159.5 (s, C6H4) ppm; 19F NMR (CDCl3, 188 MHz): –65.1 (s, CF3)
ppm; IR (film): v 30042858, 1605, 1508, 1454, 1333, 1248, 1186, 1144, 1024, 837 cm-1; HRMS (ESI-TOF):
m/z [M+Na]+ calcd for C19H21F3N2OSNa: 405.1224; found: 405.1219.
4.2.4. Spiro{adamantane-2,2’-[3’-(4’’-bromophenyl)-5’-trifluoromethyl-2’,3’-dihydro-1’,3’,4’-thiadiazole]} (9d)
Reaction time 2h; FCC (SiO2, petroleum ether/CH2Cl2 7:3), pale yellow solid, 289 mg (67%); mp
9395 C. 1H NMR (600 MHz, CDCl3): = 1.53, 1.72, 1.79-1.88, 2.04-2.07, 2.32 (5 m, 2 H, 2 H, 4 H, 4 H, 2 H,
Ad), 7.39-7.41, 7.49-7.51 (2 m, 2 H, 2 H) ppm; 13C NMR (CDCl3, 151 MHz): = 26.2, 26.5, 33.0, 37.5, 37.7,
38.0 (Ad), 97.4 (s, spiro-C), 119.6 (q, 1JC-F = 273.1 Hz, CF3), 122.5, 131.7, 132.2, 141.8 (s, 2 d, s, C6H4), 145.1
(q, 2JC-F = 38.1 Hz, C-5) ppm; 19F NMR (CDCl3, 188 MHz): = –65.1 (s, CF3) ppm; IR (KBr): 3054-2858, 1557,
1483, 1331, 1189, 1146, 1027, 965, 838 cm-1; HRMS (ESI-TOF): m/z [M+H]+ calcd for C18H19BrF3N2S:
431.0404; found: 431.0387.
10